A Phase II, 6-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel group trial with a quetiapine arm to evaluate the efficacy, tolerability and safety of oral BI 1358894 in patients with Major Depressive Disorder with inadequate response to antidepressants.

Project: Research

Project Details

Effective start/end date6/10/2031/12/24


  • Psychiatry
  • major depressive disorder
  • Clinical trial